19 - 23 September 2016
Congress Center Basel, Switzerland
Presentations
Workshop: Genome Editing: Strategies for Engineering a Model Cell Line Favorite All Download | Monday, 19 Sep 2016 | Lima
Genome Editing in Human Stem Cells - Creation of Novel and Relevant Models for Basic Research and Drug Discovery 09:15 - 09:45
Targeted Integration: Nuclease and Donor Design Considerations 09:45 - 10:15
Screening Methods: Basic and Advanced 10:30 - 11:15
Special Considerations for iPS/Stem Cells 11:15 - 12:00
Career workshops with Peggy McKee I. | Monday, 19 Sep 2016 | Kairo 1-2
LinkedIn - What you should know? 09:15 - 10:15
Career workshops with Peggy McKee II. | Monday, 19 Sep 2016 | Kairo 1-2
Resumes - 3 simple changes to get more interviews 10:30 - 11:30
Career workshops with Peggy McKee III. | Monday, 19 Sep 2016 | Kairo 1-2
Job search solutions - where are the hidden jobs? 11:45 - 12:45
Career workshops with Peggy McKee IV. | Monday, 19 Sep 2016 | Kairo 1-2
Job interviews - how to get more offers? 01:45 - 02:45
Career workshops with Peggy McKee V. | Monday, 19 Sep 2016 | Kairo 1-2
How to get a promotion? 03:00 - 04:00
Protein Production - Current challenges in protein science: from fundamental research to drug development part 1 | Tuesday, 20 Sep 2016 | Shanghai 2-3
New approaches in the selection of candidate therapeutic binders with calcium dependent fragment assembly separation technology (CD-FAST) 09:15 - 09:45
Protein production – dealing with the unpredictable 09:45 - 10:15
Stem Cells in Biomedicine part 1 | Tuesday, 20 Sep 2016 | Kairo 1-2
Metabolic regulation of neural stem cells 09:15 - 09:45
Development of iPSC-based assays for drug development in neuroscience: tauopathies as an entry point 09:45 - 10:15
Peptide Therapeutics Forum 2016 part 1 | Tuesday, 20 Sep 2016 | Delhi
Opportunities for chemical protein mimics in vaccine design 09:15 - 09:45
Brain-Shuttle - BACE1 peptide inhibitor conjugates lower brain Aβ levels 09:45 - 10:15
Basel Agenda part 2 | Tuesday, 20 Sep 2016 | Shanghai 1
New adherence potentials in joint B2C models 11:00 - 11:15
Panel Discussion 11:15 - 12:00
Medicinal Chemistry and Drug Discovery part 2 | Tuesday, 20 Sep 2016 | Lima
Drug Discovery with Small-Molecule CMRT™ Macrocycles – Design and Experience 11:00 - 11:30
Macrocycles addressing challenging therapeutic targets with unmet medical needs 11:30 - 12:00
Protein Production - Current challenges in protein science: from fundamental research to drug development part 2 | Tuesday, 20 Sep 2016 | Shanghai 2-3
Beyond the prokaryotic ribosome: structural and functional insights into eukaryotic and mitochondrial ribosomes 11:00 - 11:30
Native mass spectrometry - new perspectives for drug discovery 11:30 - 12:00
Industry Symposium - Learn How to Improve Translation of Phenotypic Assays Using IncuCyte ZOOM Live-Cell Analysis System | Tuesday, 20 Sep 2016 | Lima
Introduction to IncuCyte ZOOM® and the concept of long term live cell imaging 12:15 - 12:20
IncuCyte ZOOM® Applications in Mechanistic Safety 12:20 - 12:45
Improving the translation of phenotypic assays with IncuCyte ZOOM® live-cell analysis 12:45 - 01:05
Q&A and networking 01:05 - 01:15
Industry Symposium - Czech Centres of Excellence | Tuesday, 20 Sep 2016 | Darwin
Welcome speech 12:15 - 12:20
Keynote speech 12:20 - 12:25
IOCB Drug discovery pipeline 12:25 - 12:35
20 years of pharmaceutical research 12:35 - 12:45
Functional Genomics Programme 12:45 - 12:55
Life Sciences in the Czech Republic 12:55 - 01:10
Career workshops with Peggy McKee VI. | Tuesday, 20 Sep 2016 | Shanghai 1
Networking for Career Success 12:15 - 01:15
Welcome Words / Keynote 1. R. Mason, Johnson & Johnson | Tuesday, 20 Sep 2016 | Boston 1-3
Welcome Words 01:30 - 01:35
Introduction of the Keynote Lecture 01:35 - 01:40
Making the connection: the role of collaboration in driving innovation forward 01:40 - 02:20
Peptide Therapeutics Forum 2016 part 3 | Tuesday, 20 Sep 2016 | Delhi
Targeting peptides versus proteins by vaccination: size matters 02:30 - 03:00
Recent advances in solid phase peptide synthesis 03:00 - 03:30
Protein Production - Current challenges in protein science: from fundamental research to drug development part 3 | Tuesday, 20 Sep 2016 | Shanghai 2-3
Engineering the way to selective inhibition of human Nav1.7: a target for pain 02:30 - 03:00
Human integral membrane protein production for structural and functional studies at the SGC 03:00 - 03:30
Peptide Therapeutics Forum 2016 part 4 | Tuesday, 20 Sep 2016 | Delhi
Enabling methods for the rapid total chemical synthesis of proteins 04:15 - 04:45
Function of human type sialyloligosaccharide for the bioactivity of glycoproteins 04:45 - 05:15
Basel Agenda part 4 | Tuesday, 20 Sep 2016 | Shanghai 1
How can we make type 2 diabetes 13 times cheaper and cure the patients in doing so? 04:15 - 04:30
Panel Discussion 04:30 - 05:15
Protein Production - Current challenges in protein science: from fundamental research to drug development part 4 | Tuesday, 20 Sep 2016 | Shanghai 2-3
Directed evolution of G protein-coupled receptors: enabling structure-guided drug discovery 04:15 - 04:45
Building a complete picture: kinetics, thermodynamics and structural determination of stabilised G protein-coupled receptors 04:45 - 05:15
Infectious Diseases part 1 | Wednesday, 21 Sep 2016 | Shanghai 1
Opening Remarks 09:15 - 09:20
Common themes in the evolution of drug resistance 09:20 - 09:45
Discovery and development of novel macrocycle antibiotics 09:45 - 10:15
Best Practices in Clinical and Research Genomics and Data Warehousing part 1 | Wednesday, 21 Sep 2016 | Boston 1-3
Introduction to Best Practices 09:15 - 09:45
The role of genomics in the future of precision medicine - the UK experience 09:45 - 10:15
Jumpstarting Innovation - Early stage investing, start-up-incubation,howto enable the future generation of biotech innovators 1 | Wednesday, 21 Sep 2016 | Kairo 1-2
Introduction by BaselArea.swiss 09:15 - 09:45
What does it take to be innovative in pharma? 09:45 - 10:15
Biotherapeutics - Current challenges in protein science: from fundamental research to drug development part 1 | Wednesday, 21 Sep 2016 | Shanghai 2
The Confo®body technology, a new platform to enable fragment screening on GPCRs 09:15 - 09:45
Harnessing the Flexibility of the ExpiCHO Transient Expression System: New Uses, New Protocols and Tips for Optimizing Protein Expression 09:45 - 10:15
Aging & Drug Discovery part 1 | Wednesday, 21 Sep 2016 | Shanghai 3
Pluripotency and Aging: Novel Strategies for Intervening in Age-Related Degenerative Disease 09:15 - 09:45
Keynote 09:45 - 10:15
Peptide Therapeutics Forum 2016 part 1 | Wednesday, 21 Sep 2016 | Delhi
Making connections in peptide chemistry 09:15 - 09:45
Chemical biology of peptide natural products – structures, syntheses and bioactivities 09:45 - 10:15
Peptide Therapeutics Forum 2016 part 2 | Wednesday, 21 Sep 2016 | Delhi
Oxytocin mimetics 11:00 - 11:30
Therapeutic potential of Conus Venom peptides 11:30 - 12:00
Biotherapeutics - Current challenges in protein science: from fundamental research to drug development part 2 | Wednesday, 21 Sep 2016 | Shanghai 2
Engineering antibodies for cancer immunotherapy 11:00 - 11:30
Therapeutic antibody potentiation by antigen- and Fc-dependent IgG hexamer formation 11:30 - 12:00
Infectious Diseases part 2 | Wednesday, 21 Sep 2016 | Shanghai 1
Phage-based therapies 11:00 - 11:30
Salmonella single-cell dynamics in complex tissues 11:30 - 12:00
Jumpstarting Innovation - Early stage investing, start-up-incubation,howto enable the future generation of biotech innovators 2 | Wednesday, 21 Sep 2016 | Kairo 1-2
Immusoft Corporation 11:00 - 11:30
Company creation: Innovation in Financing & Development 11:30 - 12:00
Best Practices in Clinical and Research Genomics and Data Warehousing part 2 | Wednesday, 21 Sep 2016 | Boston 1-3
A next-generation platform for clinical data integration and real-time monitoring of clinical trials: why data and user centricity matters. 11:00 - 11:30
Protecting genomic data 11:30 - 12:00
Aging & Drug Discovery part 2 | Wednesday, 21 Sep 2016 | Shanghai 3
Strategies to get aging interventions into humans 11:00 - 11:30
Maximising healthy lifespan - a national level priority 11:30 - 12:00
Industry Symposium - Implement high-throughput 3D analysis and live-cell imaging applications | Wednesday, 21 Sep 2016 | Shanghai 3
Revolutionary tools for acquiring and analyzing 3D data from high-throughput assays 12:15 - 12:45
3D live-cell imaging applications: from subcellular structures to spheroids 12:45 - 01:15
Keynote Lecture 2. S. Gasser, FMI | Wednesday, 21 Sep 2016 | Boston 1-3
Life Sciences today and tomorrow 01:30 - 02:15
Status and Future of (Standardized) Research Data Warehouses part 1 | Wednesday, 21 Sep 2016 | Boston 1-3
Is one enough? Data warehousing for biomedical research 02:30 - 02:50
Big data variety & veracity: the roche preclinical warehouse 02:50 - 03:10
Principles of research data management 03:10 - 03:30
Biotherapeutics - Current challenges in protein science: from fundamental research to drug development part 3 | Wednesday, 21 Sep 2016 | Shanghai 2
Targeting CD47 in cancer with bispecific antibodies 02:30 - 03:00
CAP-Go: novel cell lines for the production of tailor-made glycoproteins 03:00 - 03:30
Best practices in genomics data analysis for clinical and research applications part 1 | Wednesday, 21 Sep 2016 | Shanghai 1
NGS in routine molecular diagnostic: status quo and prospective 02:30 - 03:00
The genetics clinics of the future: towards implementation of whole genome sequencing in diagnostic practice 03:00 - 03:30
Best practices in data storage integrity and security part 1 | Wednesday, 21 Sep 2016 | Lima
Blockchains as proof of data integrity in LifeScience and eHealth 02:30 - 03:00
e-Estonia: confidentiality, availability and integrity in a dynamic digital society 03:00 - 03:30
Jumpstarting Innovation - Early stage investing, start-up-incubation,howto enable the future generation of biotech innovators 3 | Wednesday, 21 Sep 2016 | Kairo 1-2
The asset-centric business model: the established trend in venture capital investing 02:30 - 03:00
Translating Innovative Science from the Laboratory to the Patien 03:00 - 03:30
Jumpstarting Innovation - Early stage investing, start-up-incubation,howto enable the future generation of biotech innovators 4 | Wednesday, 21 Sep 2016 | Kairo 1-2
Novel ways for innovators to work collaboratively with the health innovation ecosystem. The MaRS / Canada story 04:15 - 04:45
Elthera: a novel approach for targeted cancer therapy 04:45 - 05:15
Best practices in genomics data analysis for clinical and research applications part 2 | Wednesday, 21 Sep 2016 | Shanghai 1
Comprehensive molecular profiling and mining of the bibliome for personalized treatment suggestions in cancer 04:15 - 04:45
Biomarker discovery and sample stratification: a case study 04:45 - 05:15
Peptide Therapeutics Forum 2016 part 4 | Wednesday, 21 Sep 2016 | Delhi
The influence of stabilization of peptide therapeutics on their immunogenic potential 04:15 - 04:45
Further insights regarding oral bioavailability of peptides 04:45 - 05:15
Best practices in data storage integrity and security part 2 | Wednesday, 21 Sep 2016 | Lima
Ensuring healthcare system integrity with blockchain 04:15 - 04:45
Unlocking the value of blockchain in healthcare 04:45 - 05:15
Biotherapeutics - Current challenges in protein science: from fundamental research to drug development part 4 | Wednesday, 21 Sep 2016 | Shanghai 2
Bispecific FynomAbs: novel modes of action through tailored architecture 04:15 - 04:45
Enabling the Generation of Multi-Functional Drugs for Ophthalmology and Oncology with DARPins 04:45 - 05:15
Best practices in data storage integrity and security part 1 | Thursday, 22 Sep 2016 | Darwin
Optimal secure storage model for genomic data 09:15 - 09:45
Storage for Inforgs 09:45 - 10:15
Molecular Diagnostics brought by NTN Swiss Biotech part 1 | Thursday, 22 Sep 2016 | Shanghai 1
The future of personalized healthcare: the importance of diagnostics and molecular information from an industry perspective 09:15 - 09:45
Biomolecular computing circuits for diagnostics and therapy 09:45 - 10:15
Best practices in genomics data analysis for clinical and research applications part 1 | Thursday, 22 Sep 2016 | Kairo 1-2
Integrative NGS for Drug Discovery and Precision Medicine 09:15 - 09:45
Cell Free, Cell-Bound, and Cross-Kingdom DNA Benchmarking 09:45 - 10:15
Basel Microfluidics Workshop 2016 Opening/Key Note session | Thursday, 22 Sep 2016 | Delhi
Welcome & Introduction 09:15 - 09:30
Elevator-Pitches given from the organising Partners 09:30 - 09:50
Lab on chip - microfluidics, history, "organ on chip" and biomimetic channel networks 09:50 - 10:15
Aging & Drug Discovery part 1 | Thursday, 22 Sep 2016 | Shanghai 3
Genomic approaches for discovery of lifespan interventions 09:15 - 09:45
Aging and Drug Discovery 09:45 - 10:15
Synthetic Biology part 1 | Thursday, 22 Sep 2016 | Shanghai 2
Artificial metalloenzymes for synthetic biology purposes 09:15 - 09:45
Reimagine SequenceSpaceTM 09:45 - 10:00
Synergy Forum part 1 | Thursday, 22 Sep 2016 | Lima
Methods to assess Synergy 09:15 - 09:45
In vitro therapeutic synergy and iterative search for promising drug combinations 09:45 - 10:15
Best practices in genomics data analysis for clinical and research applications part 2 | Thursday, 22 Sep 2016 | Kairo 1-2
Open Forum 11:00 - 12:00
Synergy Forum part 2 | Thursday, 22 Sep 2016 | Lima
Mass-action law algorithms for quantitative simulation of interactions of multiple drug combinations 11:00 - 11:30
Discussion 11:30 - 12:00
Best practices in data storage integrity and security part 2 | Thursday, 22 Sep 2016 | Darwin
Management and Integration of data from multiple sources 11:00 - 11:30
Data storage for 100,000 Genome Project 11:30 - 12:00
Keynote 3. S. Silberberg, NIH | Thursday, 22 Sep 2016 | Boston 1-3
Increasing the predictive value of preclinical research 01:30 - 02:15
Best Practices in Clinical and Research Genomics and Data Warehousing part 1 | Thursday, 22 Sep 2016 | Boston 1-3
Genome Data Analysis Summary 02:30 - 03:00
Data Warehousing Summary 03:00 - 03:30
Jumpstarting Innovation - Early stage investing,startup-incubation,how to enable the future generation of biotech innovators 1 | Thursday, 22 Sep 2016 | Kairo 1-2
Opening remarks: Innovation Forum Lausanne 02:30 - 02:40
Cell to Cellestia Biotech AG: Transition from basic research to a Biotech company 02:40 - 02:55
Organoids for high-throughput screenings 02:55 - 03:10
JLINX : Accelerating early-stage transformative innovation - a partnership between J&J Innovation, Janssen & BioQube Ventures 03:10 - 03:30
Aging & Drug Discovery part 3 | Thursday, 22 Sep 2016 | Shanghai 3
The regulatory landscape of APP processing 02:30 - 03:00
The Intersection of mTOR Modulation, Aging, and Drug Development: Finding a Road Forward 03:00 - 03:30
Jumpstarting Innovation - Early stage investing,startup-incubation,how to enable the future generation of biotech innovators 2 | Thursday, 22 Sep 2016 | Kairo 1-2
Biotech Beyond the Third Dimension 04:15 - 04:30
Anokion: Launching a Platform Technology 04:30 - 04:50
Institutionalized generation of disruptive biotech ventures 04:50 - 05:10
Closing remarks: Innovation Forum Lausanne 05:10 - 05:15
Basel Microfluidics Workshop 2016 Application Session about Drug Development & Delivery | Thursday, 22 Sep 2016 | Delhi
Microfluidic synthesis of targeted drugs 04:15 - 04:30
Using microfluidic encapsulation for developing sustained release microspheres 04:30 - 04:45
Organs-on-chip technology for preclinical testing 04:45 - 05:00
Moderated Panel Discussion with the Presenters 05:00 - 05:15
Aging & Drug Discovery part 4 | Thursday, 22 Sep 2016 | Shanghai 3
Intervention in accelerated aging 04:15 - 04:45
Panel Discussion: Current Issues in Aging & Longevity 04:45 - 05:15
Best Practices in Clinical and Research Genomics and Data Warehousing part 2 | Thursday, 22 Sep 2016 | Boston 1-3
Data storage integrity and security summary 04:15 - 04:45
The barriers to the delivery of Precision Medicine 04:45 - 05:15